3 active not recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Active not recruiting 3 |
Follow Ischemic Stroke: new trials by email Literature Review of Ischemic Stroke trials Research Report on Ischemic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment Extract of Ginkgo Biloba Leaves Tablets 240 mg (2 x 40 mg, t.i.d.), Standard of care (SoC) Group - Ischemic Stroke Hospitalized, Impairment, Cognitive | Phase 4 | Active not recruiting | Dr. Willmar Schwabe GmbH & Co. KG | 400 | 2025-11-28 | 2026-10-30 |
| Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE Antiplatelet Drug, Warfarin - Antiphospholipid Syndrome, Ischemic Stroke | Phase 4 | Active not recruiting | Seoul National University Hospital | 200 | 2024-02-20 | 2026-09-11 |
| Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion (MIST-B) Minocycline - Ischemic Stroke, Acute, Minocycline | Phase 4 | Active not recruiting | Xijing Hospital | 90 | 2023-03-04 | 2025-05-30 |
Antiphospholipid Syndrome (1) · Cardiovascular Diseases (1) · Cerebrovascular Disorders (1) · Cognitive Dysfunction (1) · Ischemic Attack, Transient (1) · Thrombosis (1) · cyclopia sequence (1)
Brain Diseases (3) · Central Nervous System Diseases (3) · Nervous System Diseases (3) · Stroke (3) · Vascular Diseases (3) · Cardiovascular Diseases (2) · Cerebrovascular Disorders (2) · Autoimmune Diseases (1) · Brain Ischemia (1) · Cognition Disorders (1) · Embolism and Thrombosis (1) · Immune System Diseases (1) · Mental Disorders (1) · Neurocognitive Disorders (1)
Minocycline (1) · Platelet Aggregation Inhibitors (1) · Population Groups (1) · Standard of Care (1) · Warfarin (1)
Dr. Willmar Schwabe GmbH & Co. KG (1) · Seoul National University Hospital (1) · Xijing Hospital (1)
China (2) · South Korea (1)
Petra Klement (1) · Seung-Hoon Lee, MD, PhD (1)